메뉴 건너뛰기




Volumn 2012, Issue , 2012, Pages

Serum CEACAM1 correlates with disease progression and survival in malignant melanoma patients

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; PROTEIN S100B; CANCER VACCINE; CD66 ANTIGENS; CELL ADHESION MOLECULE; LEUKOCYTE ANTIGEN; LIVE VACCINE; NERVE GROWTH FACTOR; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT; TUMOR MARKER;

EID: 84856405473     PISSN: 17402522     EISSN: 17402530     Source Type: Journal    
DOI: 10.1155/2012/290536     Document Type: Article
Times cited : (25)

References (44)
  • 1
    • 36849030243 scopus 로고    scopus 로고
    • Management of Metastatic Melanoma
    • DOI 10.1053/j.seminoncol.2007.09.008, PII S0093775407001844, Malignant Melanoma
    • Tawbi H. A., Kirkwood J. M., Management of metastatic melanoma Seminars in Oncology 2007 34 6 532 545 (Pubitemid 350236308)
    • (2007) Seminars in Oncology , vol.34 , Issue.6 , pp. 532-545
    • Tawbi, H.A.1    Kirkwood, J.M.2
  • 2
    • 38049019119 scopus 로고    scopus 로고
    • Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: A review of clinical trials
    • Takimoto C. H., Awada A., Safety and anti-tumor activity of sorafenib (Nexavar) in combination with other anti-cancer agents: a review of clinical trials Cancer Chemotherapy and Pharmacology 2008 61 4 535 548
    • (2008) Cancer Chemotherapy and Pharmacology , vol.61 , Issue.4 , pp. 535-548
    • Takimoto, C.H.1    Awada, A.2
  • 3
    • 0035665036 scopus 로고    scopus 로고
    • Progress in the development of immunotherapy for the treatment of patients with cancer
    • DOI 10.1046/j.1365-2796.2001.00911.x
    • Rosenberg S. A., Progress in the development of immunotherapy for the treatment of patients with cancer Journal of Internal Medicine 2001 250 6 462 475 (Pubitemid 34013510)
    • (2001) Journal of Internal Medicine , vol.250 , Issue.6 , pp. 462-475
    • Rosenberg, S.A.1
  • 4
    • 0038129922 scopus 로고    scopus 로고
    • Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma
    • DOI 10.1016/S0093-7754(03)00097-6
    • Christianson D. F., Anderson C. M., Close monitoring and lifetime follow-up is optimal for patients with a history of melanoma Seminars in Oncology 2003 30 3 369 374 (Pubitemid 36706561)
    • (2003) Seminars in Oncology , vol.30 , Issue.3 , pp. 369-374
    • Christianson, D.F.1    Anderson, C.M.2
  • 5
    • 0031929106 scopus 로고    scopus 로고
    • Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases
    • Barnhill R. L., Piepkorn M. W., Cochran A. J., Flynn E., Karaoli T., Folkman J., Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases Archives of Dermatology 1998 134 8 991 994 (Pubitemid 28385321)
    • (1998) Archives of Dermatology , vol.134 , Issue.8 , pp. 991-994
    • Barnhill, R.L.1    Piepkorn, M.W.2    Cochran, A.J.3    Flynn, E.4    Karaoli, T.5    Folkman, J.6
  • 6
    • 0033032641 scopus 로고    scopus 로고
    • S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma
    • Deichmann M., Benner A., Bock M., Jckel A., Uhl K., Waldmann V., Nher H., S100-beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American Joint Committee on Cancer stage IV melanoma Journal of Clinical Oncology 1999 17 6 1891 1896 (Pubitemid 29269262)
    • (1999) Journal of Clinical Oncology , vol.17 , Issue.6 , pp. 1891-1896
    • Deichmann, M.1    Benner, A.2    Bock, M.3    Jackel, A.4    Uhl, K.5    Waldmann, V.6    Naher, H.7
  • 7
    • 4344701616 scopus 로고    scopus 로고
    • Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase
    • Deichmann M., Kahle B., Moser K., Wacker J., Wst K., Diagnosing melanoma patients entering American Joint Committee on Cancer stage IV, C-reactive protein in serum is superior to lactate dehydrogenase British Journal of Cancer 2004 91 4 699 702 (Pubitemid 39141627)
    • (2004) British Journal of Cancer , vol.91 , Issue.4 , pp. 699-702
    • Deichmann, M.1    Kahle, B.2    Moser, K.3    Wacker, J.4    Wust, K.5
  • 8
    • 0036446555 scopus 로고    scopus 로고
    • Comparison of prognostic significance of serum 5-S-cysteinyldopa, LDH and S-100B protein in stage III-IV malignant melanoma
    • Bnfalvi T., Boldizsr M., Gergye M., Gilde K., Kremmer T., Ott S., Comparison of prognostic significance of serum 5-S-cysteinyldopa, LDH and S-100B protein in stage III-IV malignant melanoma Pathology and Oncology Research 2002 8 3 183 187 (Pubitemid 35407638)
    • (2002) Pathology Oncology Research , vol.8 , Issue.3 , pp. 183-187
    • Banfalvi, T.1    Boldizsar, M.2    Gergye, M.3    Gilde, K.4    Kremmer, T.5    Otto, S.6
  • 9
    • 3042685214 scopus 로고    scopus 로고
    • S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma
    • DOI 10.1016/j.clinbiochem.2004.05.012, PII S0009912004001353
    • Harpio R., Einarsson R., S100 proteins as cancer biomarkers with focus on S100B in malignant melanoma Clinical Biochemistry 2004 37 7 512 518 (Pubitemid 38845014)
    • (2004) Clinical Biochemistry , vol.37 , Issue.7 , pp. 512-518
    • Harpio, R.1    Einarsson, R.2
  • 12
    • 0031798536 scopus 로고    scopus 로고
    • The luminescence immunoassay S-100: A sensitive test to measure circulating S-100B: Its prognostic value in malignant melanoma
    • Bonfrer J. M. G., Korse C. M., Nieweg O. E., Rankin E. M., The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma British Journal of Cancer 1998 77 12 2210 2214 (Pubitemid 28263943)
    • (1998) British Journal of Cancer , vol.77 , Issue.12 , pp. 2210-2214
    • Bonfrer, J.M.G.1    Korse, C.M.2    Nieweg, O.E.3    Rankin, E.M.4
  • 13
    • 0033023956 scopus 로고    scopus 로고
    • Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy
    • DOI 10.1046/j.1365-2133.1999.02905.x
    • Hauschild A., Engel G., Brenner W., Glser R., Mnig H., Henze E., Christophers E., Predictive value of serum S100B for monitoring patients with metastatic melanoma during chemotherapy and/or immunotherapy British Journal of Dermatology 1999 140 6 1065 1071 (Pubitemid 29284578)
    • (1999) British Journal of Dermatology , vol.140 , Issue.6 , pp. 1065-1071
    • Hauschild, A.1    Engel, G.2    Brenner, W.3    Glaser, R.4    Monig, H.5    Henze, E.6    Christophers, E.7
  • 14
    • 0035015137 scopus 로고    scopus 로고
    • S100β is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase
    • Krhn G., Kaskel P., Sander S., Pereira Y Waizenhfer J., Wortmann S., Leiter U., Peter R. U., S100 is a more reliable tumor marker in peripheral blood for patients with newly occurred melanoma metastases compared with MIA, albumin and lactate-dehydrogenase Anticancer Research 2001 21 2 B 1311 1316 (Pubitemid 32494139)
    • (2001) Anticancer Research , vol.21 , Issue.2 B , pp. 1311-1316
    • Krahn, G.1    Kaskel, P.2    Sander, S.3    Pereira, Y.4    Waizenhofer, J.5    Wortmann, S.6    Leiter, U.7    Peter, R.U.8
  • 16
    • 0029783592 scopus 로고    scopus 로고
    • Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy
    • Keilholz U., Scheibenbogen C., Sommer M., Pritsch M., Geuke A. M., Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy Melanoma Research 1996 6 2 173 178 (Pubitemid 26259032)
    • (1996) Melanoma Research , vol.6 , Issue.2 , pp. 173-178
    • Keilholz, U.1    Scheibenbogen, C.2    Sommer, M.3    Pritsch, M.4    Geuke, A.-M.5
  • 17
    • 0036124933 scopus 로고    scopus 로고
    • S-100 protein serum levels in patients with benign and malignant diseases: False-positive results related to liver and renal function
    • DOI 10.1159/000048687
    • Molina R., Navarro J., Filella X., Castel T., Ballesta A. M., S-100 protein serum levels in patients with benign and malignant diseases: false-positive results related to liver and renal function Tumor Biology 2002 23 1 39 44 (Pubitemid 34225020)
    • (2002) Tumor Biology , vol.23 , Issue.1 , pp. 39-44
    • Molina, R.1    Navarro, J.2    Filella, X.3    Castel, T.4    Ballesta, A.M.5
  • 18
    • 0031925404 scopus 로고    scopus 로고
    • Cellular-source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura
    • DOI 10.1002/(SICI)1098-1101(19 98)13:1<16::AID-JC A3>3.0.CO;2-C
    • Cohen J. A., Brecher M. E., Bandarenko N., Cellular-source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura Journal of Clinical Apheresis 1998 13 1 16 19 (Pubitemid 28215135)
    • (1998) Journal of Clinical Apheresis , vol.13 , Issue.1 , pp. 16-19
    • Cohen, J.A.1    Brecher, M.E.2    Bandarenko, N.3
  • 19
    • 0020470409 scopus 로고
    • Peliosis hepatis. Report of two autopsy cases with a review of the literature
    • Asano S., Wakasa H., Kaise S., Peliosis hepatis. Report of two autopsy cases with a review of the literature Acta Pathologica Japonica 1982 32 5 861 877 (Pubitemid 13252944)
    • (1982) Acta Pathologica Japonica , vol.32 , Issue.5 , pp. 861-877
    • Asano, S.1    Wakasa, H.2    Kaise, S.3
  • 21
    • 33745684548 scopus 로고    scopus 로고
    • CEACAM1: Contact-dependent control of immunity
    • Gray-Owen S. D., Blumberg R. S., CEACAM1: contact-dependent control of immunity Nature Reviews Immunology 2006 6 6 433 446
    • (2006) Nature Reviews Immunology , vol.6 , Issue.6 , pp. 433-446
    • Gray-Owen, S.D.1    Blumberg, R.S.2
  • 22
    • 33748310638 scopus 로고    scopus 로고
    • CEACAMs: Their role in physiology and pathophysiology
    • DOI 10.1016/j.ceb.2006.08.008, PII S0955067406001189
    • Kuespert K., Pils S., Hauck C. R., CEACAMs: their role in physiology and pathophysiology Current Opinion in Cell Biology 2006 18 5 565 571 (Pubitemid 44332912)
    • (2006) Current Opinion in Cell Biology , vol.18 , Issue.5 , pp. 565-571
    • Kuespert, K.1    Pils, S.2    Hauck, C.R.3
  • 24
    • 0030917224 scopus 로고    scopus 로고
    • Decreased expression of biliary glycoprotein in hepatocellular carcinomas
    • DOI 10.1002/(SICI)1097-0215(1997 0220)74:1<15::AID-IJ C3>3.0.CO;2-3
    • Tanaka K., Hinoda Y., Takahashi H., Sakamoto H., Nakajima Y., Imai K., Decreased expression of biliary glycoprotein in hepatocellular carcinomas International Journal of Cancer 1997 74 1 15 19 (Pubitemid 27157849)
    • (1997) International Journal of Cancer , vol.74 , Issue.1 , pp. 15-19
    • Tanaka, K.1    Hinoda, Y.2    Takahashi, H.3    Sakamoto, H.4    Nakajima, Y.5    Imai, K.6
  • 25
    • 7244234272 scopus 로고    scopus 로고
    • The tumour suppressor gene CEACAMI is completely but reversibly downregulated in renal cell carcinoma
    • DOI 10.1002/path.1657
    • Kammerer R., Riesenberg R., Weiler C., Lohrmann J., Schleypen J., Zimmermann W., The tumour suppressor gene CEACAMI is completely but reversibly downregulated in renal cell carcinoma Journal of Pathology 2004 204 3 258 267 (Pubitemid 39430084)
    • (2004) Journal of Pathology , vol.204 , Issue.3 , pp. 258-267
    • Kammerer, R.1    Riesenberg, R.2    Weiler, C.3    Lohrmann, J.4    Schleypen, J.5    Zimmermann, W.6
  • 26
    • 0036239847 scopus 로고    scopus 로고
    • Down-regulation of CEACAM1 in human prostate cancer: Correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition
    • DOI 10.1053/hupa.2002.32218
    • Busch C., Hanssen T. A., Wagener C., Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition Human Pathology 2002 33 3 290 298 (Pubitemid 34461462)
    • (2002) Human Pathology , vol.33 , Issue.3 , pp. 290-298
    • Busch, C.1    Hanssen, T.A.2    Wagener, C.3
  • 27
    • 0029585326 scopus 로고
    • Inhibition of colonic tumor cell growth by biliary glycoprotein
    • Kunath T., Ordoez-Garcia C., Turbide C., Beauchemin N., Inhibition of colonic tumor cell growth by biliary glycoprotein Oncogene 1995 11 11 2375 2382 (Pubitemid 26008415)
    • (1995) Oncogene , vol.11 , Issue.11 , pp. 2375-2382
    • Kunath, T.1    Ordonez-Garcia, C.2    Turbide, C.3    Beauchemin, N.4
  • 28
    • 0028897315 scopus 로고
    • Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches
    • Hsieh J. T., Luo W., Song W., Wang Y., Kleinerman D. I., Van N. T., Lin S. H., Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches Cancer Research 1995 55 1 190 197
    • (1995) Cancer Research , vol.55 , Issue.1 , pp. 190-197
    • Hsieh, J.T.1    Luo, W.2    Song, W.3    Wang, Y.4    Kleinerman, D.I.5    Van, N.T.6    Lin, S.H.7
  • 32
    • 67149131793 scopus 로고    scopus 로고
    • Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions
    • Gambichler T., Grothe S., Rotterdam S., Altmeyer P., Kreuter A., Protein expression of carcinoembryonic antigen cell adhesion molecules in benign and malignant melanocytic skin lesions American Journal of Clinical Pathology 2009 131 6 782 787
    • (2009) American Journal of Clinical Pathology , vol.131 , Issue.6 , pp. 782-787
    • Gambichler, T.1    Grothe, S.2    Rotterdam, S.3    Altmeyer, P.4    Kreuter, A.5
  • 38
    • 0023093741 scopus 로고
    • Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma
    • Muul L. M., Spies P. J., Director E. P., Rosenberg S. A., Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma Journal of Immunology 1987 138 3 989 995 (Pubitemid 17012424)
    • (1987) Journal of Immunology , vol.138 , Issue.3 , pp. 989-995
    • Mesler Muul, L.1    Spies, P.J.2    Director, E.P.3    Rosenberg, S.A.4
  • 41
    • 0017089971 scopus 로고
    • The induction of hapten specific T cell tolerance by using hapten modified lymphoid cells. I. Characteristics of tolerance induction
    • Miller S. D., Claman H. N., The induction of hapten specific T cell tolerance by using hapten modified lymphoid cells. I. Characteristics of tolerance induction Journal of Immunology 1976 117 5
    • (1976) Journal of Immunology , vol.117 , Issue.5
    • Miller, S.D.1    Claman, H.N.2
  • 43
    • 73949120017 scopus 로고    scopus 로고
    • Melanoma biomarkers: Current status and vision for the future
    • Larson A. R., Konat E., Alani R. M., Melanoma biomarkers: current status and vision for the future Nature Clinical Practice Oncology 2009 6 2 105 117
    • (2009) Nature Clinical Practice Oncology , vol.6 , Issue.2 , pp. 105-117
    • Larson, A.R.1    Konat, E.2    Alani, R.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.